J. Brown

发表

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution

S. Gabriel, E. Lander, G. Getz, 2015, Nature Communications.

The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan.

J. Brown, P. Colville-Nash, D. Willis, 1997, Cancer research.

The inhibition of neutrophil-endothelial cell adhesion by hyaluronan independent of CD44

M. Carrier, J. Brown, P. Colville-Nash, 2006, InflammoPharmacology.

Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia.

M. Chiarini, E. V. Van Allen, Winston A Hide, 2016, Blood.

Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis

J. Ritz, J. Brown, K. Stevenson, 2011, Bone Marrow Transplantation.

The pharmacological modulation of angiogenesis in chronic granulomatous inflammation.

J. Brown, P. Colville-Nash, D. Willoughby, 1995, The Journal of pharmacology and experimental therapeutics.

Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study

J. Byrd, J. Brown, C. Dearden, 2017, Blood Cancer Journal.

Phase I study of CAL-101, an isoform-selective inhibitor of phosphatidylinositol 3-kinase P110d, in patients with previously treated chronic lymphocytic leukemia.

R. Ulrich, J. Byrd, I. Flinn, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preliminary evidence of clinical activity in a phase I study of CAL-101, a selective inhibitor of the p1108 isoform of phosphatidylinositol 3-kinase (P13K), in patients with select hematologic malignancies.

J. Byrd, I. Flinn, J. Brown, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL

D. Neuberg, J. Ritz, A. Freedman, 2010, Leukemia.

A PIVOTAL, RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED, TWO‐ARM, PHASE 2 STUDY OF ME‐401 INVESTIGATING TWO DOSING SCHEDULES IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) AFTER FAILURE OF TWO OR MORE PRIOR SYSTEMIC THERAPIES

A. Zelenetz, P. Abrisqueta, C. Buske, 2019, Hematological Oncology.

Adenosine- and adenine-nucleotide-mediated inhibition of normal and transformed keratinocyte proliferation is dependent upon dipyridamole-sensitive adenosine transport.

J. Brown, K. Cornell, P. Cook, 2000, The Journal of investigative dermatology.

Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype.

J. Brown, M. Pittelkow, C. Clegg, 1997, The Journal of clinical investigation.

Systematic genomic screen for tyrosine kinase mutations in CLL

D. Gilliland, R. Levine, A. Freedman, 2008, Leukemia.

Mutational landscape and underlying mutational processes in chronic lymphocytic leukemia

S. Kasar, J. Brown, 2016, Molecular & cellular oncology.

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL

Jennifer H. Lin, J. Byrd, U. Jaeger, 2017, Leukemia.

Germline copy number variation associated with Mendelian inheritance of CLL in two families

N. Pochet, D. Neuberg, Y. Peer, 2012, Leukemia.

Substance P selectively activates TNF-alpha gene expression in murine mast cells.

J. Brown, D. Payan, M. Brown, 1993, Journal of immunology.

Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents

J. Brown, A. Berger, A. Danilov, 2015, Cell Death and Disease.

Pityriasis rubra pilaris‐like erythroderma secondary to phosphoinositide 3‐kinase inhibition

J. Brown, D. Fisher, N. LeBoeuf, 2018, Clinical and experimental dermatology.

Paradoxical embolism after peripheral blood stem cell infusion

J. Brown, G. Kao, K. Darabi, 2005, Bone Marrow Transplantation.

Apoptosis induction and inhibition of colon-26 tumour growth and angiogenesis: findings on COX-1 and COX-2 inhibitors in vitro & in vivo and topical diclofenac in hyaluronan.

J. Brown, P. Colville-Nash, D. Willoughby, 1997, Advances in experimental medicine and biology.

The modulation of granulomatous tissue and tumour angiogenesis by diclofenac in combination with hyaluronan (HYAL EX-0001).

J. Brown, D. Willoughby, M. Seed, 1995, International journal of tissue reactions.

Ongoing phase I studies of ABT-263: Mitigating Bcl-XL induced thrombocytopenia with lead-in and continuous dosing.

W. Wilson, C. Rudin, J. Brown, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.